- Home
- CHNR vs BDRX Comparison
CHNR vs BDRX Comparison
Compare CHNR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- BDRX
- Stock Information
- Founded
- CHNR N/A
- BDRX 2000
- Country
- CHNR China
- BDRX United Kingdom
- Employees
- CHNR N/A
- BDRX N/A
- Industry
- CHNR Precious Metals
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- BDRX Health Care
- Exchange
- CHNR Nasdaq
- BDRX Nasdaq
- Market Cap
- CHNR 4.6M
- BDRX 3.8M
- IPO Year
- CHNR 1995
- BDRX N/A
- Fundamental
- Price
- CHNR $3.90
- BDRX $5.65
- Analyst Decision
- CHNR
- BDRX
- Analyst Count
- CHNR 0
- BDRX 0
- Target Price
- CHNR N/A
- BDRX N/A
- AVG Volume (30 Days)
- CHNR 18.0K
- BDRX 22.8K
- Earning Date
- CHNR 05-15-2025
- BDRX 09-29-2025
- Dividend Yield
- CHNR N/A
- BDRX N/A
- EPS Growth
- CHNR N/A
- BDRX N/A
- EPS
- CHNR N/A
- BDRX N/A
- Revenue
- CHNR N/A
- BDRX N/A
- Revenue This Year
- CHNR N/A
- BDRX N/A
- Revenue Next Year
- CHNR N/A
- BDRX N/A
- P/E Ratio
- CHNR N/A
- BDRX N/A
- Revenue Growth
- CHNR N/A
- BDRX N/A
- 52 Week Low
- CHNR $3.16
- BDRX $5.29
- 52 Week High
- CHNR $9.04
- BDRX $112.85
- Technical
- Relative Strength Index (RSI)
- CHNR 54.53
- BDRX 34.03
- Support Level
- CHNR $3.57
- BDRX $5.29
- Resistance Level
- CHNR $4.24
- BDRX $5.96
- Average True Range (ATR)
- CHNR 0.20
- BDRX 0.48
- MACD
- CHNR 0.05
- BDRX 0.01
- Stochastic Oscillator
- CHNR 59.04
- BDRX 18.55
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.